The Toronto Blue Jays are taking a shot at some pitching depth beyond the 2026 season.
Righty reliever Nic Enright has signed a two-year minor-league deal with the Blue Jays but will spend the 2026 season rehabbing from Tommy John surgery, ESPN’s Alden Gonzalez reported Tuesday.
Enright, 28, had a solid 2025 season with the Cleveland Guardians after beating a case of Hodgkin lymphoma, a type of blood cancer. He pitched to a 2.03 ERA and 1.161 WHIP in 27 appearances before undergoing Tommy John surgery in early October.
He’s expected to return to the mound in 2027 should his recovery go according to plan.
The Richmond, Va., native was selected by the Guardians in the 20th round of the 2019 Draft and made his major-league debut in 2025.
Enright was diagnosed with Stage 2 Hodgkin lymphoma in 2022 and underwent immunotherapy treatment in 2023, into the start of 2024. While undergoing treatment, he continued to pitch, earning a 4.97 ERA in 34 appearances across three minor-league levels in 2023.
He improved to a 1.06 ERA in 16 triple-A appearances in 2024, parlaying his success into his breakout 2025 campaign to earn his MLB call-up.
